Insulin Treatment Attenuates Decline of Muscle Mass in Japanese Patients with Type 2 Diabetes

Sarcopenia is defined as an age-related loss of skeletal muscle mass and strength, and is a major cause of disability and mobility limitations. Recent studies have demonstrated that type 2 diabetes and insulin signaling deficiencies contribute to the progression of sarcopenia, suggesting that a suff...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Calcif Tissue Int
Auteurs principaux: Bouchi, Ryotaro, Fukuda, Tatsuya, Takeuchi, Takato, Nakano, Yujiro, Murakami, Masanori, Minami, Isao, Izumiyama, Hajime, Hashimoto, Koshi, Yoshimoto, Takanobu, Ogawa, Yoshihiro
Format: Artigo
Langue:Inglês
Publié: Springer US 2017
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5486921/
https://ncbi.nlm.nih.gov/pubmed/28246927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00223-017-0251-x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires